Model 4195 Left Ventricular (LV) Lead Chronic Performance Study
NCT ID: NCT00869921
Last Updated: 2018-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1322 participants
OBSERVATIONAL
2009-03-31
2018-04-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Model 4196 Left Ventricular (LV) Lead Chronic Performance Study
NCT00930904
Attain StarFix® 4195 Lead Extraction Study
NCT00893386
Model 4396 Left Ventricular (LV) Lead Chronic Performance Study
NCT01361685
Attain Performa™ Left Ventricular (LV) Quadripolar Leads Chronic Performance Study
NCT02294331
Model 4296 Left Ventricular (LV) Lead Chronic Performance Study
NCT01361672
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient has or is intended to receive an Attain StarFix Model 4195 LV lead
* Patient within 30 day post implant enrollment window
Exclusion Criteria
* Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
4195 LV Lead Chronic Performance Study Team
Role: STUDY_CHAIR
Medtronic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Anchorage, Alaska, United States
Phoenix, Arizona, United States
Scottsdale, Arizona, United States
Chula Vista, California, United States
Redding, California, United States
Salinas, California, United States
Stanford, California, United States
Torrance, California, United States
Colorado Springs, Colorado, United States
New Haven, Connecticut, United States
Bradenton, Florida, United States
Clearwater, Florida, United States
Jacksonville, Florida, United States
Melbourne, Florida, United States
Albany, Georgia, United States
Marietta, Georgia, United States
Indianapolis, Indiana, United States
Newburgh, Indiana, United States
Des Moines, Iowa, United States
Kansas City, Kansas, United States
Edgewood, Kentucky, United States
Louisville, Kentucky, United States
Baton Rouge, Louisiana, United States
Covington, Louisiana, United States
Salisbury, Maryland, United States
Silver Spring, Maryland, United States
Takoma Park, Maryland, United States
Boston, Massachusetts, United States
Grand Blanc, Michigan, United States
Marquette, Michigan, United States
Robbinsdale, Minnesota, United States
Rochester, Minnesota, United States
Saint Louis Park, Minnesota, United States
Columbia, Missouri, United States
Kansas City, Missouri, United States
Henderson, Nevada, United States
West Orange, New Jersey, United States
Albuquerque, New Mexico, United States
New York, New York, United States
Durham, North Carolina, United States
Fargo, North Dakota, United States
Cincinnati, Ohio, United States
Cleveland, Ohio, United States
Columbus, Ohio, United States
Toledo, Ohio, United States
Portland, Oregon, United States
Lancaster, Pennsylvania, United States
Germantown, Tennessee, United States
Kingsport, Tennessee, United States
Nashville, Tennessee, United States
Austin, Texas, United States
Dallas, Texas, United States
Fort Worth, Texas, United States
Houston, Texas, United States
Plano, Texas, United States
San Antonio, Texas, United States
Burlington, Vermont, United States
Falls Church, Virginia, United States
Olympia, Washington, United States
Spokane, Washington, United States
Madison, Wisconsin, United States
Milwaukee, Wisconsin, United States
Calgary, Alberta, Canada
Kingston, Ontario, Canada
Ottawa, Ontario, Canada
Québec, Quebec, Canada
Middlesbrough, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4195 Chronic Performance
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.